KOSPIInsurance000400

Lotte Non-Life Insurance

₩2,470▼ 0.40%2026-11-18 close
Market Cap
₩766.5B
Turnover
₩900M
Volume
350K
Shares out.
310M
PER
—
PBR
1.0×
EPS
-₩518
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Insurance Core in the Black, Investment Losses Decide Results

Lotte Non-Life Insurance keeps posting insurance operating profits led by long-term insurance, but investment losses pushed the third quarter of 2026 into an operating and net loss while Shinhan Financial Group moves to take control.

  1. 1

    Insurance operations stayed profitable. Cumulative insurance operating profit for the first nine months of 2026 reached KRW 73.5 billion, up 99.4% from a year earlier, with long-term insurance at the core.

  2. 2

    Investment results pulled the quarter under. A third-quarter investment operating loss of KRW 139.2 billion turned the quarter into an operating loss of KRW 119.4 billion and a net loss of KRW 93.7 billion.

  3. 3

    Ownership is changing. Shinhan Financial Group agreed to buy a 77.04% stake for KRW 693.3 billion, with the remaining shares and a merger with the group's existing non-life insurer EZ planned after regulatory approval.

  4. 4

    New contractual service margin (CSM), the source of future insurance profit, came to KRW 214.1 billion for the first nine months of 2026, down 32.0% from a year earlier.

  5. 5

    The attributable net loss for the last four quarters totals KRW 159.9 billion. Full-year 2025 operating profit was KRW 64.7 billion, up 108.4%, a recovery from the prior year's shortfall.

02

Business structure

Lotte Non-Life Insurance is a non-life insurer whose main line is long-term insurance. Long-term protection premiums written in the first nine months of 2026 reached KRW 1.92 trillion, up 1.6% from a year earlier.

Of the KRW 19.8 billion insurance operating profit in the third quarter alone, long-term insurance contributed KRW 25.0 billion, which implies that the non-long-term lines were a net loss in aggregate.

Contractual service margin (CSM) is the balance of future insurance profit that is recognized gradually over the life of the contracts. Retained CSM stood at KRW 2.24 trillion at the end of September 2026, down 9.4% from KRW 2.47 trillion at the end of 2025.

On the asset side, the value of fund holdings and rate-sensitive bonds declined, producing losses. Total assets fell from KRW 14.4 trillion at the end of 2025 to KRW 13.4 trillion at the end of September 2026. The ownership structure is also changing.

According to October 2026 press reports, Shinhan Financial Group agreed to acquire a 77.04% stake in Lotte Non-Life Insurance for KRW 693.3 billion. In competition, the gap in retained CSM versus the larger non-life insurers is wide, and analysts expect profitability gains to appear over the medium to long term. The company has named portfolio improvement in long-term insurance and expense efficiency as its priorities.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩532B₩68B12.8%
2025Q4₩558.8B-₩64.6B−11.6%
2026Q1₩551.6B-₩28.5B−5.2%
2026Q2₩553.5B₩3.1B0.6%
2026Q3₩553.8B-₩119.4B−21.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.5T-₩125.1B-₩99.2B—−5.5%829.8%
2023₩1.6T₩396.3B₩301.6B—24.0%1081.5%
2024₩2T₩31.1B₩24.2B—3.0%1856.8%
2025₩2.1T₩64.7B₩51.3B—8.4%2248.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a reported basis, insurance revenue rose from KRW 1.49 trillion in 2022 to KRW 2.13 trillion in 2025, with three consecutive years of growth from 2023 through 2025. The 2025 increase was 7.7%.

Operating profit swung from an operating loss of KRW 125.1 billion in 2022 to operating profit of KRW 396.3 billion in 2023, then fell 92.2% to KRW 31.1 billion in 2024 before rising 108.4% to KRW 64.7 billion in 2025.

Attributable net income was KRW 301.6 billion in 2023, KRW 24.2 billion in 2024 and KRW 51.3 billion in 2025. Net income including non-controlling interests and attributable net income were reported at the same amounts for each year from 2022 through 2025. The capital structure weakened.

The debt ratio rose from 829.8% in 2022 to 2,248.9% in 2025, with total liabilities of KRW 13.8 trillion and total equity of KRW 613.5 billion at the end of 2025, all of it attributable to shareholders.

Operating cash flow went from an inflow of KRW 2.13 trillion in 2023 to outflows of KRW 207 billion in 2024 and KRW 722.1 billion in 2025.

Quarterly, operating profit of KRW 68 billion in the third quarter of 2025 became an operating loss of KRW 64.6 billion in the fourth quarter, returned to a small profit of KRW 3.06 billion in the second quarter of 2026, and then turned into an operating loss of KRW 119.4 billion in the third quarter of 2026.

Insurance revenue rose in the second and third quarters of 2026, yet profit moved the other way because of investment results.

Cumulative insurance operating profit for the first nine months of 2026 reached KRW 73.5 billion, but cumulative investment results swung to a loss of KRW 218.3 billion, leaving a cumulative net loss of KRW 112.2 billion.

The company frames the valuation losses on rate-sensitive bonds as recoverable as markets stabilize. The attributable net loss for the last four quarters totals KRW 159.9 billion.

05

Industry analysis

Analysts view Lotte Non-Life Insurance as having a wide gap in retained CSM versus the larger non-life insurers, and expect profitability gains to appear over the medium to long term.

The rationale presented for Shinhan's acquisition cites the group's relatively thin non-life lineup after its 2019 acquisition of Orange Life. Non-life insurers are highly sensitive to the rate environment.

In the third quarter of 2026, rising domestic and overseas market rates lowered the value of rate-sensitive bonds, and fluctuations in fund holdings were also booked as losses.

Investment yields also weakened, with cumulative yield on securities at 0.67% for the first nine months of 2026, against 3.71% for full-year 2025. On the regulatory side, the adoption of the actuarial assumption advancement framework in the second quarter reduced the CSM balance.

Long-term protection premiums rose only 1.6% to KRW 1.92 trillion for the first nine months, so top-line growth was modest. A 32.0% drop in new business CSM suggests weaker profit creation from newly written long-term contracts.

Larger peers include Samsung Fire & Marine Insurance and DB Insurance, and the scale gap leaves portfolio improvement and expense efficiency as open tasks.

06

Outlook

The company has said it will strengthen a stable earnings base through portfolio improvement in insurance, expense efficiency and careful management of investment assets.

The company expects valuation losses on rate-sensitive bonds to recover as markets stabilize, since these bonds can be redeemed at maturity at face value. Shinhan's acquisition is set to proceed through regulatory approval, followed by purchase of the remaining shares and a merger with EZ.

One brokerage analyst judged the purchase price reasonable and said group synergies could lift medium-to-long-term profitability. The same analyst flagged a decline in the CET1 ratio, the need for additional capital and the absence of dividend receipts for a considerable period as partial negatives on cash flow.

Analysts agree that the key question is whether Lotte Non-Life's earnings normalize. With new business CSM down 32.0% in the first nine months of 2026, the recovery of new business is the first checkpoint for the core business.

The CSM balance reduced by the second-quarter adoption of the actuarial assumption framework also needs to be watched for recovery. The next periodic report is the 2026 annual report, due by March 31, 2027.

07

Valuation

PER
—
PBR
1.0×
ROE
-23.0%
EPS
-₩518
BPS
₩2,460
Dividend per share
₩0

Because the attributable net loss for the last four quarters totals KRW 159.9 billion, the price-to-earnings ratio cannot be calculated. When earnings cannot anchor valuation, asset-based measures are referenced more often. The price-to-book ratio sits near the book value of capital.

Total equity of KRW 613.5 billion at the end of 2025 equals the equity attributable to shareholders, so non-controlling interests do not affect the figure. Total liabilities of KRW 13.8 trillion are far larger than equity, so leverage is a precondition for reading the valuation.

The dividend yield is below the industry average, and the earnings structure does not rely on dividends. Shinhan's KRW 693.3 billion payment buys a 77.04% stake, so any asset-value reading of the deal should be made on a stake basis. The main ground brokerages use to judge the price is whether earnings normalize.

The valuation reading depends on whether investment results stabilize and whether insurance operating profit carries through to net income.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Long-term insurance keeps underwriting profitable

Cumulative insurance operating profit for the first nine months of 2026 reached KRW 73.5 billion, up 99.4%. The third quarter alone contributed KRW 19.8 billion, up KRW 4.6 billion, with long-term insurance producing KRW 25.0 billion. Full-year 2025 operating profit of KRW 64.7 billion rose 108.4%. The continuing profit in the core business is the main bullish argument.

Group ownership strengthens the non-life lineup

Shinhan Financial Group agreed to buy 77.04% for KRW 693.3 billion. The remaining shares would be acquired and a merger with EZ pursued. Brokerage commentary viewed the reinforcement of the group's non-life lineup and medium-to-long-term profitability gains positively. Group ownership opens the possibility of synergies in the operating base and expense structure.

Room for recovery in rate-sensitive bond losses

The company says rate-sensitive bonds can be repaid at face value at maturity. It expects valuation losses to recover once markets stabilize. The third-quarter investment operating loss of KRW 139.2 billion reflected rate and currency moves along with fund valuation losses. If market conditions normalize, the direction of valuation gains and losses could change.

09

Bear factors

High volatility in investment results

The standalone third-quarter investment operating loss was KRW 139.2 billion. Cumulative investment results swung from a KRW 92.4 billion gain a year earlier to a KRW 218.3 billion loss. Cumulative securities yield for the first nine months of 2026 was 0.67%, below the 3.71% recorded for full-year 2025. Investment losses offsetting insurance profit is the main bearish argument.

Lower new business CSM and a smaller retained balance

New business CSM for the first nine months of 2026 was KRW 214.1 billion, down 32.0%. Retained CSM at the end of September 2026 was KRW 2.24 trillion, down 9.4% from KRW 2.47 trillion at the end of 2025. The second-quarter adoption of the actuarial assumption framework also reduced the CSM balance. A weaker source of future insurance profit is the main bearish concern.

Earnings normalization and capital strain

With net losses continuing, the debt ratio rose from 829.8% in 2022 to 2,248.9% at the end of 2025. Brokerage commentary flagged the decline in the CET1 ratio and the lack of dividend receipts for a considerable period as cash-flow negatives. If earnings do not normalize, capital pressure could grow.

10

Risk factors

Rates, currency and valuation gains or losses

The third-quarter investment loss reflected rate and currency moves together with valuation losses on investment assets. The company said it booked fund value changes conservatively. If domestic and overseas market rates keep rising, further valuation losses on rate-sensitive bonds could follow. Quarterly swings could remain large as long as results depend on asset management.

Acquisition and merger process

Shinhan's acquisition requires regulatory approval and other steps. The purchase of the remaining shares and the planned merger with EZ still have procedures ahead. If approval conditions or timing change, the timing and effect of the ownership shift would also change. Management direction and business strategy could shift before the deal closes.

Capital ratio and leverage

Total equity at the end of 2025 was KRW 613.5 billion, against total liabilities of KRW 13.8 trillion. The debt ratio of 2,248.9% is high. The gap in CSM with the larger non-life insurers means recovery in recurring profitability could take time. Limited capital room could delay growth investment or the resumption of dividends.

11

What to watch next

  1. After December 2026 (timing not fixed)

    The next checkpoints are the regulatory approval outcome for Shinhan's acquisition and the timetable for the remaining shares. Whether the planned merger with EZ takes a concrete form also needs to be watched.

  2. By March 31, 2027

    The 2026 annual report is the next periodic filing. It will be the first audited full-year disclosure showing operating profit and the investment result structure for 2026.

  3. By May 15, 2027

    The first-quarter 2027 quarterly report is due by the filing deadline. Whether investment valuation losses recover and whether insurance operating profit stays positive are the points to confirm.

12

Overall view

Lotte Non-Life Insurance's long-term insurance-led operations delivered cumulative operating profit of KRW 73.5 billion for the first nine months of 2026, and full-year 2025 operating profit rose 108.4%.

Investment losses, however, produced a third-quarter operating loss of KRW 119.4 billion and a net loss of KRW 93.7 billion, and the attributable net loss for the last four quarters totals KRW 159.9 billion.

A 32.0% drop in new business CSM and a debt ratio of 2,248.9% remain open issues for the core business and the capital base. Shinhan's stake purchase and the planned merger with EZ change both ownership and capital structure.

Analysts treat whether earnings normalize as the central question, and the CET1 decline and dividend constraints are flagged as near-term burdens. Positive factors are the continuation of insurance operating profit, the possibility of recovery in rate-sensitive bond losses and the group ownership effect.

Negative factors are the volatility of investment results, lower new business and high leverage. The next checkpoints are the 2026 annual report, due by March 31, 2027, the first-quarter 2027 report, and the regulatory approval process.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. news.ifm.kr
  2. insnews.co.kr
  3. dailian.co.kr
  4. koreastocknews.com
  5. supple.kr
  6. newsway.co.kr
  7. job-post.co.kr
  8. mydaily.co.kr
  9. comp.wisereport.co.kr
  10. itooza.com
  11. comp.fnguide.com
  12. google.com
  13. fnnews.com
  14. comp.wisereport.co.kr
  15. paxnet.co.kr
  16. judal.co.kr
  17. seo.goover.ai

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis